# Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain

> **NCT04908748** · PHASE2 · COMPLETED · sponsor: **Teikoku Seiyaku Co., Ltd.** · enrollment: 200 (actual)

## Conditions studied

- Soft Tissue Injuries
- Contusions
- Strains
- Sprains
- Bruises

## Interventions

- **DRUG:** Esflurbiprofen Hydrogel Patch

## Key facts

- **NCT ID:** NCT04908748
- **Lead sponsor:** Teikoku Seiyaku Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-20
- **Primary completion:** 2021-11-09
- **Final completion:** 2021-12-15
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2023-09-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04908748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04908748, "Efficacy and Safety of Esflurbiprofen Hydrogel Patch in the Treatment of Local Acute Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04908748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*